BR0013729A - Radiopharmaceuticals and their preparation procedures - Google Patents

Radiopharmaceuticals and their preparation procedures

Info

Publication number
BR0013729A
BR0013729A BR0013729-4A BR0013729A BR0013729A BR 0013729 A BR0013729 A BR 0013729A BR 0013729 A BR0013729 A BR 0013729A BR 0013729 A BR0013729 A BR 0013729A
Authority
BR
Brazil
Prior art keywords
preparation procedures
products
radiopharmaceuticals
group
sequestering groups
Prior art date
Application number
BR0013729-4A
Other languages
Portuguese (pt)
Inventor
Emmanuel Bellande
Pierre Jallet
Benoit Denizot
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BR0013729A publication Critical patent/BR0013729A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: "PRODUTOS RADIOFARMACêUTICOS E SEUS PROCEDIMENTOS DE PREPARAçãO". A presente invenção refere-se aos produtos e seus procedimentos de preparação. Estes produtos podem ser usados para cintigrafia ou para terapia. Eles compreendem um polissacarídeo e grupos sequestrantes das fórmulas R-NH-, R-N=, e fórmula (I) em que R é um grupo hidrocarbónico ou aromático compreendendo pelo menos um átomo de enxofre, R' é um átomo de hidrogênio ou um grupamento de alquila tal como metila, os referidos grupos sequestrantes formando um complexo tipo quelato com um metal radioativo tal como tecnécio.Patent of Invention: "RADIOPHARMACEUTICAL PRODUCTS AND THEIR PREPARATION PROCEDURES". The present invention relates to the products and their preparation procedures. These products can be used for scintigraphy or for therapy. They comprise a polysaccharide and sequestering groups of the formulas R-NH-, RN =, and formula (I) wherein R is a hydrocarbon or aromatic group comprising at least one sulfur atom, R 'is a hydrogen atom or a group of alkyl such as methyl, said sequestering groups forming a chelate-like complex with a radioactive metal such as technetium.

BR0013729-4A 1999-09-01 2000-08-23 Radiopharmaceuticals and their preparation procedures BR0013729A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910970A FR2797769B1 (en) 1999-09-01 1999-09-01 RADIOPHARMACEUTICAL PRODUCTS AND THEIR PREPARATION PROCESS
PCT/IB2000/001161 WO2001015746A1 (en) 1999-09-01 2000-08-23 Radiopharmaceutical products and their preparation procedure

Publications (1)

Publication Number Publication Date
BR0013729A true BR0013729A (en) 2002-05-07

Family

ID=9549465

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013729-4A BR0013729A (en) 1999-09-01 2000-08-23 Radiopharmaceuticals and their preparation procedures

Country Status (23)

Country Link
EP (1) EP1210127A1 (en)
JP (1) JP2003508455A (en)
KR (1) KR20020040799A (en)
CN (1) CN1371292A (en)
AU (1) AU6463100A (en)
BG (1) BG106438A (en)
BR (1) BR0013729A (en)
CA (1) CA2383517A1 (en)
CZ (1) CZ2002782A3 (en)
EA (1) EA200200307A1 (en)
EE (1) EE200200105A (en)
FR (1) FR2797769B1 (en)
HK (1) HK1044893A1 (en)
HU (1) HUP0202714A2 (en)
IL (1) IL148076A0 (en)
MX (1) MXPA02001923A (en)
NO (1) NO20021001L (en)
NZ (1) NZ517377A (en)
PL (1) PL353803A1 (en)
SK (1) SK2772002A3 (en)
WO (1) WO2001015746A1 (en)
YU (1) YU14202A (en)
ZA (1) ZA200201057B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
FR2919189A1 (en) * 2007-07-26 2009-01-30 Cyclopharma Sa Lab NOVEL COMPOSITIONS BASED ON POLYOSIDES GRAFTED BY POLYAMINE OR POLYSOUFRE COMPOUNDS.
CN102977174B (en) * 2012-12-19 2015-04-22 北京师范大学 99mTc(CO)3 nuclear-labeled macrocyclic polyamine triazole ring glucose-based complex as well as preparation and application of complex
PL240772B1 (en) 2018-06-11 2022-06-06 Nanothea Spolka Akcyjna Method of producing polymer nanoparticles chelating radioactive isotopes for use in diagnostics and treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7412164L (en) * 1974-09-27 1976-03-29 Pharmacia Ab FUNDS FOR INTRAVASCULAR ADMINISTRATION
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
AU5085793A (en) * 1992-09-04 1994-03-29 General Hospital Corporation, The Biocompatible polymers containing diagnostic or therapeutic moieties
US5958372A (en) * 1994-06-28 1999-09-28 Nycomed Imaging As Low viscosity chelating polymers for diagnostic imaging
FR2736834B1 (en) * 1995-07-17 1997-08-29 Cis Bio Int RADIOPHARMACEUTICAL PRODUCTS WITH CARDIAC TROPISM COMPRISING A NITRURO COMPLEX OF A TRANSITIONAL METAL AND HAVING FAST MYOCARDIAL CLEARANCE

Also Published As

Publication number Publication date
ZA200201057B (en) 2003-07-30
KR20020040799A (en) 2002-05-30
NO20021001L (en) 2002-04-11
CZ2002782A3 (en) 2002-08-14
YU14202A (en) 2004-09-03
NZ517377A (en) 2003-08-29
MXPA02001923A (en) 2003-07-21
EE200200105A (en) 2003-04-15
AU6463100A (en) 2001-03-26
EA200200307A1 (en) 2002-08-29
BG106438A (en) 2002-09-30
WO2001015746A1 (en) 2001-03-08
CN1371292A (en) 2002-09-25
SK2772002A3 (en) 2002-09-10
NO20021001D0 (en) 2002-02-28
EP1210127A1 (en) 2002-06-05
IL148076A0 (en) 2002-09-12
FR2797769A1 (en) 2001-03-02
JP2003508455A (en) 2003-03-04
CA2383517A1 (en) 2001-03-08
HUP0202714A2 (en) 2002-12-28
HK1044893A1 (en) 2002-11-08
FR2797769B1 (en) 2003-07-25
PL353803A1 (en) 2003-12-01

Similar Documents

Publication Publication Date Title
BR0013729A (en) Radiopharmaceuticals and their preparation procedures
BR0111377A (en) Thiophene derivatives useful as anticancer agents
AR018633A1 (en) BENZO DERIVATIVES (B) TIEPIN-1,1-DIOXIDE, PROCEDURE FOR PREPARATION, MEDICATIONS CONTAINING THESE COMPOUNDS AND THEIR EMPLOYMENT
BR0014116A (en) Use of a compound, compound, methods for preparing a compound, and to inhibit aurora 2 kinase in a warm-blooded animal, and pharmaceutical composition
ATE218554T1 (en) HEPATOBILLIAN MAGNETIC RESONANCE CONTRAST AGENTS
ATE5258T1 (en) (PIPERIDINYLALKYL)QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
HUP0302422A2 (en) Cathartic composition
IL60390A (en) Piperidine derivatives,their preparation and pharmaceutical compositions comprising them
BRPI1011683B8 (en) substituted isoquinoline derivatives, their pharmaceutical compositions and their uses
BR0312798A (en) Isothiazole derivatives useful as anticancer agents
KR870007118A (en) Optically pure compound and preparation method thereof
SE7706126L (en) RADIOACTIVE PREPARATION
MX9200485A (en) PROCESS FOR OBTAINING DERIVATIVES OF TETRA HIDRO PIRIDINA AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
ES8205802A1 (en) Substituted thienotricycles, process for their preparation and therapeutical agents containing them.
ES2131549T3 (en) 16-LINK MACROLID DERIVATIVES AND THEIR PREPARATION PROCEDURE.
ES480602A1 (en) Indole derivatives, their preparation and use in pharmaceutical compositions.
ES428818A1 (en) N-substituted 1-amino-3-phenoxy-propan-2-ol compounds and therapeutic compositions containing them
AR013208A1 (en) AN AQUEOUS LIQUID DETERGENT COMPOSITION AND A PROCEDURE FOR PREPARING IT
AR024671A1 (en) DERIVATIVES OF BENZOFURAN, A PROCEDURE FOR THEIR PREPARATION, AND THE USE OF THE SAME AS INTERMEDIATE PRODUCTS FOR THE SYNTHESIS OF MEDICINES
ZA81863B (en) 5,6; 8,9-tetrahydro-7h-dibenz(d,f)azonine derivatives, the preparation thereof and compositions
BR0206660A (en) Plant seed paste formulation
ES543793A0 (en) PROCEDURE FOR THE PREPARATION OF NEW A-ETILBEN-ZOL DERIVATIVES WITH A SUBSTITUTED PIPERIDINOPROPANOLIC GROUP AND ITS QUADRONARY AMONIC AND ACID ADDITIONAL SALTS
BR9800956A (en) Pharmaceutical composition that acts by inhibiting serine proteases, and, medicine
ES383467A1 (en) Procedure for the preparation of pirrol derivatives. (Machine-translation by Google Translate, not legally binding)
BR9811307A (en) Carbohydrate derivative or a salt thereof, agents to prevent and treat dermatopathy or dermatitis and to inhibit skin erythema and / or skin pigmentation, compound, use of a compound, and, process for preparing a carbohydrate derivative

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1927 DE 11/12/2007.